50 related articles for article (PubMed ID: 8698067)
1. Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy.
Würker M; Herholz K; Voges J; Pietrzyk U; Treuer H; Bauer B; Sturm V; Heiss WD
Eur J Nucl Med; 1996 May; 23(5):583-6. PubMed ID: 8698067
[TBL] [Abstract][Full Text] [Related]
2. The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.
Galldiks N; Law I; Pope WB; Arbizu J; Langen KJ
Neuroimage Clin; 2017; 13():386-394. PubMed ID: 28116231
[TBL] [Abstract][Full Text] [Related]
3. Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response Monitoring.
Challapalli A; Aboagye EO
Front Oncol; 2016; 6():44. PubMed ID: 26973812
[TBL] [Abstract][Full Text] [Related]
4. From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?
Galldiks N; Langen KJ; Pope WB
Neuro Oncol; 2015 Nov; 17(11):1434-44. PubMed ID: 26130743
[TBL] [Abstract][Full Text] [Related]
5. Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods.
Ahmed R; Oborski MJ; Hwang M; Lieberman FS; Mountz JM
Cancer Manag Res; 2014; 6():149-70. PubMed ID: 24711712
[TBL] [Abstract][Full Text] [Related]
6. Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.
Waerzeggers Y; Ullrich RT; Monfared P; Viel T; Weckesser M; Stummer W; Schober O; Winkeler A; Jacobs AH
Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S179-95. PubMed ID: 22433828
[TBL] [Abstract][Full Text] [Related]
7. Iodine-125 brachytherapy for brain tumours--a review.
Schwarz SB; Thon N; Nikolajek K; Niyazi M; Tonn JC; Belka C; Kreth FW
Radiat Oncol; 2012 Mar; 7():30. PubMed ID: 22394548
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic brachytherapy of low-grade cerebral glioma after tumor resection.
Suchorska B; Ruge M; Treuer H; Sturm V; Voges J
Neuro Oncol; 2011 Oct; 13(10):1133-42. PubMed ID: 21868412
[TBL] [Abstract][Full Text] [Related]
9. Molecular imaging of gliomas with PET: opportunities and limitations.
la Fougère C; Suchorska B; Bartenstein P; Kreth FW; Tonn JC
Neuro Oncol; 2011 Aug; 13(8):806-19. PubMed ID: 21757446
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II.
Smits A; Baumert BG
Int J Mol Imaging; 2011; 2011():372509. PubMed ID: 21603237
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of glioma and radiation injury in rats using in vitro produce magnetically labeled cytotoxic T-cells and MRI.
Arbab AS; Janic B; Jafari-Khouzani K; Iskander AS; Kumar S; Varma NR; Knight RA; Soltanian-Zadeh H; Brown SL; Frank JA
PLoS One; 2010 Feb; 5(2):e9365. PubMed ID: 20195476
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy.
Ford EC; Herman J; Yorke E; Wahl RL
J Nucl Med; 2009 Oct; 50(10):1655-65. PubMed ID: 19759099
[TBL] [Abstract][Full Text] [Related]
13. Diagnostics of cerebral gliomas with radiolabeled amino acids.
Langen KJ; Tatsch K; Grosu AL; Jacobs AH; Weckesser M; Sabri O
Dtsch Arztebl Int; 2008 Jan; 105(4):55-61. PubMed ID: 19633770
[TBL] [Abstract][Full Text] [Related]
14. Imaging biological activity of a glioblastoma treated with an individual patient-tailored, experimental therapy regimen.
Galldiks N; Ullrich R; Schroeter M; Fink GR; Kracht LW
J Neurooncol; 2009 Jul; 93(3):425-30. PubMed ID: 19183853
[TBL] [Abstract][Full Text] [Related]
15. Molecular imaging of brain tumors: a bridge between clinical and molecular medicine?
Schaller BJ; Modo M; Buchfelder M
Mol Imaging Biol; 2007; 9(2):60-71. PubMed ID: 17203238
[TBL] [Abstract][Full Text] [Related]
16. Serial O-(2-[(18)F]fluoroethyl)-L: -tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma.
Pöpperl G; Götz C; Rachinger W; Schnell O; Gildehaus FJ; Tonn JC; Tatsch K
Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):792-800. PubMed ID: 16550381
[TBL] [Abstract][Full Text] [Related]
17. Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas.
Galldiks N; Kracht LW; Burghaus L; Thomas A; Jacobs AH; Heiss WD; Herholz K
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):516-24. PubMed ID: 16450140
[TBL] [Abstract][Full Text] [Related]
18. PET imaging of brain astrocytoma with 1-11C-acetate.
Liu RS; Chang CP; Chu LS; Chu YK; Hsieh HJ; Chang CW; Yang BH; Yen SH; Huang MC; Liao SQ; Yeh SH
Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):420-7. PubMed ID: 16404596
[TBL] [Abstract][Full Text] [Related]
19. Imaging in neurooncology.
Jacobs AH; Kracht LW; Gossmann A; Rüger MA; Thomas AV; Thiel A; Herholz K
NeuroRx; 2005 Apr; 2(2):333-47. PubMed ID: 15897954
[TBL] [Abstract][Full Text] [Related]
20. O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma.
Pöpperl G; Goldbrunner R; Gildehaus FJ; Kreth FW; Tanner P; Holtmannspötter M; Tonn JC; Tatsch K
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1018-25. PubMed ID: 15877226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
